Pricing Log in Create free account

Intensity Therapeutics Inc. (INTS) vs Lipocine Inc. (LPCN)

Intensity Therapeutics Inc. and Lipocine Inc. are both Biotechnology companies. Lipocine Inc. is the larger, with a market value of $12.6M against $10.1M — 1.2× the size. Intensity Therapeutics Inc. has the higher net margin (0.00% vs −249.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Lipocine Inc. leads on 8 and Intensity Therapeutics Inc. on 6.

Valuation

Metric INTS LPCN Biotechnology median
P/E n/m n/m 10.26
P/S n/m 3.37 9.18
P/B 0.87 0.60 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.12 0.58 0.65
EV/Sales n/m (1.58) 8.98
Earnings yield (164.06%) (88.89%) (34.89%)
Free cash flow yield (111.37%) (80.16%) (24.52%)

Profitability

Metric INTS LPCN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (269.05%) 0.00%
Net margin 0.00% (249.16%) 0.00%
Free cash flow margin 0.00% (267.37%) 0.00%
Return on equity (195.88%) (52.86%) (50.12%)
Return on assets (139.85%) (47.52%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INTS LPCN Biotechnology median
Revenue growth (TTM) — (13.36%) 6.26%
EPS growth (last fiscal year) 70.74% (93,988.89%) 29.88%
Revenue growth, 5-year CAGR — 64.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INTS LPCN Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.00 11.36 4.89
Net debt to EBITDA 0.99 1.42 1.01

Dividend

Metric INTS LPCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INTS LPCN Biotechnology median
Market cap 10.12m 12.61m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack